Completed NA INTERVENTIONAL 2-arm NCT06348095

Effect of Probiotics on Mycoplasma Pneumoniae Pneumonia

Effect of Probiotic WecProB on the Course of Mycoplasma Pneumoniae Pneumonia in Children

Sponsor: Wecare Probiotics Co., Ltd.

Conditions Mycoplasma Pneumoniae Pneumonia

Updated 5 times since 2024 Last updated: Feb 28, 2026 Started: Jun 1, 2024 Primary completion: Mar 20, 2025 Completion: Aug 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06348095, this NA trial focuses on Mycoplasma Pneumoniae Pneumonia and remains completed. Sponsored by Wecare Probiotics Co., Ltd., it has been updated 5 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Mar 2026 — Present [monthly]

Completed NA

Status: Not Yet Recruiting → Completed
Sep 2024 — Mar 2026 [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Jun 2024 — Jul 2024 [monthly]

Not Yet Recruiting NA
May 2024 — Jun 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Wecare Probiotics Co., Ltd.

Data source: Wecare Probiotics Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chongqing, China